AI Startup Funding in Early 2026: The Biggest Raises and What They Signal

The AI funding market entered 2026 at a pace that has surprised even optimistic analysts. According to data from BestBrokers, using PitchBook and CB Insights data, AI startups raised approximately $220 billion in just the first eight weeks of 2026 — with $189 billion raised in February alone. For context, Q1 2025 total AI funding was $75.5 billion.

The scale is driven primarily by a small number of enormous rounds at the top of the market. OpenAI raised $110 billion in February 2026 — reported by TechCrunch as one of the largest private funding rounds ever — at a valuation approaching $500 billion. Anthropic closed a $30 billion Series G at a $380 billion post-money valuation in February 2026, with the round co-led by Coatue and Singapore's GIC, per TechCrunch reporting. xAI (Elon Musk's AI company) raised $20 billion in January 2026 from NVIDIA, Cisco, and Fidelity.

The K-Shaped Funding Market

The headline numbers mask a deeply bifurcated market. According to Carta data reported by TechCrunch, AI startups accounted for 41% of the $128 billion raised by companies on the Carta platform in 2025 — a record high. But 10% of startups accounted for 50% of the funding. The market is concentrating rapidly into a small number of companies with proven technology and massive compute requirements.

Peter Walker, head of insights at Carta, summarised the dynamic directly: "Fewer bets, but more capital. AI startups are raising bigger rounds not because they have lots of employees — they don't — but because the cost of running AI models is high."

Notable Raises Beyond the Mega-Rounds

Among companies raising $100 million or more in early 2026, several notable patterns emerge from TechCrunch's verified funding tracker:

• ElevenLabs (voice AI): $500M Series D led by Sequoia, valuing the company at $11 billion
• Baseten (AI infrastructure): $300M Series E at $5 billion valuation, led by IVP and CapitalG
• Decagon (conversational AI): $250M Series D
• OpenEvidence (medical AI): $250M Series D at $12 billion valuation
• Figure AI (humanoid robotics): Raised over $1B in a September 2025 Series C at a $39 billion valuation, with backers including NVIDIA, Qualcomm, and Salesforce

Where Investor Conviction Is Concentrating

Reading across the Crunchbase 2026 predictions report and PitchBook's Q1 2026 analyst notes, several clear investment themes are emerging:

Infrastructure over applications: The largest rounds are going to companies building the underlying infrastructure — compute, model APIs, data pipelines — rather than consumer-facing applications. Enterprise AI revenue reached $37 billion in 2025, up more than 3x year-over-year, per Menlo Ventures' generative AI report.

Physical AI: Robotics and embodied AI attracted significant investor attention. Funding for humanoid-focused startups exceeded $1.3 billion in H1 2025 alone (AI Summit/Crunchbase data), and the pace has continued into 2026.

Healthcare AI: Medical AI is seeing renewed investment following a quieter 2024. OpenEvidence's $12 billion valuation and several other healthcare AI raises signal growing institutional confidence in the regulatory pathway for AI-assisted clinical tools.

The Sustainability Question

The pace of 2026 funding has prompted legitimate questions about sustainability. Crunchbase's year-ahead forecast, compiled from investor interviews, describes 2026 as a "fundamentals-first year where capital rewards revenue growth, efficiency and real AI advantage, and punishes anything that is AI veneer on old ideas." The days of funding AI-adjacent businesses primarily on the strength of the AI label appear to be ending. What comes next will be determined by which companies can convert their capital into durable revenue.